A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
- Llombart-Cussac, A.
- Pivot, X.
- Biganzoli, L.
- Cortes-Funes, H.
- Pritchard, K.I.
- Pierga, J.-Y.
- Smith, I.
- Thomssen, C.
- Srock, S.
- Sampayo, M.
- Cortes, J.
ISSN: 1532-3080, 0960-9776
Year of publication: 2014
Volume: 23
Issue: 5
Pages: 656-662
Type: Article